Adjunctive antibiotics show efficacy for small skin infections
Adding antibiotic treatment to standard drainage of simple skin abscesses appears to improve healing, researchers reported on June 29, 2017 in the NEJM/New England Journal of Medicine.
Adding antibiotic treatment to standard drainage of simple skin abscesses appears to improve healing, researchers reported on June 29, 2017 in the NEJM/New England Journal of Medicine.
An entertaining case discussion session, chaired by Craig Moskowitz at ICML-14, highlighted some of the hot debates in Hodgkin lymphoma as discussed here by Professor Stephen Ansell (Rochester, USA),… read more.
Interviewer: Esther Drain Dr Toby Eyre (Oxford), Professor Anas Younes (MSKCC, USA), Dr Andrew Davies (Southampton) and Dr Graham Collins (Oxford) discuss new data in CAR T cell therapy and the first EZH2 inhibitor, tazemetostat, in… read more.
By Maria Dalby (article) and Esther Drain (interviews) Even in an era of rapid progress in terms of new agents and treatment approaches, stem cell transplantation (SCT) continues… read more.
By Maria Dalby (article) and Esther Drain (interviews) Not only is the treatment ‘landscape’ in Hodgkin lymphoma (HL) changing rapidly both in the first-line and relapsed/refractory setting, but… read more.
The old mantra is that advanced follicular lymphoma (FL) cannot be cured and treatment does not influence survival but this is no longer the case – follicular lymphoma… read more.
Scientists in Germany have successfully reprogrammed liver cells, turning them into pancreas progenitor cells by altering a single gene. The team behind the breakthrough, at the Max Delbrück… read more.
Scientists in Germany have successfully reprogrammed liver cells, turning them into pancreas progenitor cells by altering a single gene. The team behind the breakthrough, at the Max Delbrück… read more.
The 1,000th study has been uploaded to the European Union (EU) electronic Register of Post-Authorisation Studies (EU PAS Register), a significant landmark in the transparency initiative.
Double-hit lymphoma has a poor prognosis and the best option for patients could be positive identification and treatment with novel agents, but there are arguments for and against… read more.
Chronic, cancer-related fatigue (CRF) is associated with a sudden- onset, profound lack of energy that is not relieved by rest. It is different from the fatigue experienced by… read more.
Even in the era of novel therapies for newly-diagnosed and relapsed/refractory MM, there is a group of patients for whom the myeloma biology significantly shortens life expectancy. Allogeneic… read more.